Enzymatica enters agreement with Sanofi for covering France and Italy on common cold spray Coldzyme®
Enzymatica and Sanofi Consumer Health Care, part of the French pharmaceutical group Sanofi, have entered an agreement for marketing, distribution and sales of Enzymatica’s cold spray ColdZyme® in France and Italy. The two countries represent some of the largest OTC markets in Europe with a total population of nearly 130 million. Sanofi expects to launch ColdZyme under their established trademarks in these markets during the cough & cold seasons 2020/2021.Sanofi is ranked number one in volume and number two in value on the European consumer health care market after GSK/Pfizer with a